3rd Quarter - Report
WINNING STRATEGIES WASHINGTON for NOVARTIS
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY12 Department of Defense Appropriations Orphan drugs and tax issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Health Issues HCR
Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and progress of the deficit reduction committee
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.